Trinity Biotech - ADR Financials

$9.60

$0.00 (0.00%)

As on 04-Sep-2026 12:33EDT

Market cap

$8 Mln

Revenue (TTM)

$54 Mln

P/E Ratio

--

P/B Ratio

5.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	43.79	61.56	56.83	62.52	81.15	101.98
Cost of Revenue	26.90	40.11	37.38	52.73	54.89	53.40
Gross Profit	16.89	21.44	19.45	22.05	33.45	48.58
Operating Expenses	28.30	42.61	46.50	32.96	29.52	48.50
Operating Profit (EBIT)	-11.42	-21.17	-27.05	-15.27	3.94	0.08
Other Income	--	--	--	--	--	--
Profit before Tax	-37.18	-30.73	-36.93	-43.78	-1.92	-6.63
Provision for Tax	0.20	0.49	-0.06	-0.19	-0.07	-0.62
Profit after Tax (Net Income)	-37.38	-31.79	-24.02	-41.00	0.88	-6.39
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	0.88	-6.39

Liabilities ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	-71.98	-35.18	-23.95	-2.18	-0.32	-2.22
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	35.94	106.38	68.35	76.94	18.72	105.56
Current Liabilities	141.21	32.10	15.04	17.34	100.49	27.06
Total Liabilities	105.17	103.29	59.44	92.10	118.90	130.40

Assets ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	69.26	62.17	20.39	45.44	46.21	47.10
Current Assets	35.90	41.12	39.04	46.67	72.69	83.30
Total Assets	105.17	103.29	59.44	92.10	118.90	130.40
Total Debt*	137.98	100.76	67.43	72.20	99.16	104.34
Net Current Assets	-105.31	9.03	24.01	29.33	-27.80	56.24

Cashflow ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	-5.93	-4.19	-11.56	-0.92	13.24	23.76
Cash Flow from Investing Activities	-6.22	-22.97	24.76	-5.98	-8.69	-10.20
Cash from Financing Activities	12.05	28.81	-16.04	-12.32	-6.02	-2.72
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-60.10	-67.29	-2.71	-161.36	5.00	-0.24
Cash EPS ($)	-55.78	-63.34	-2.51	-152.18	20.67	-0.12
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-9.53	-8.87	-1.30	-3.62	75.60	0.89
Free Cash Flow per Share ($)	-19.54	-30.18	-1.39	-27.15	25.97	0.51

Profitability Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	-56.81	-58.30	-42.32	-48.56	0.87	-6.11
ROE (%)	69.76	107.52	183.87	3,286.73	-68.95	-512.27
ROA (%)	-35.86	-39.07	-31.70	-38.86	0.70	-4.89
EBIT Margin (%)	-54.96	-30.49	-45.53	-30.46	9.67	0.12
Net Margin (%)	-85.36	-51.64	-42.26	-65.58	1.08	-6.26
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-0.29	0.08	-0.09	-0.23	-0.20	0.13
EBIT Growth (%)	-28.20	27.46	-35.85	-342.69	6,550.85	100.48
Net Profit Growth (%)	-17.58	-32.35	41.42	-4,785.94	113.70	-57.11
EPS Growth (%)	0.11	-23.86	0.98	-33.29	21.86	-0.50
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	-0.01	-0.01	-0.16	-0.01	0.29	-15.90
Price / Book Value	-0.01	-0.01	-0.16	-0.12	-0.78	-45.78
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-6.24	-5.68	-2.80	-3.94	6.94	55.90
Close Price ($)	23.73	660.15	1,612.50	3,712.50	5,362.50	14,287.50
High Price ($)	2,580.00	2,625.00	4,650.00	5,812.50	25,580.25	18,525.00
Low Price ($)	23.10	562.50	1,387.50	3,225.00	5,175.00	2,103.75
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	-1.92	-2.86	-2.82	-33.18	-310.84	-47.02
Short term debt to equity ratio	-1.54	-0.07	-0.08	-0.87	-267.37	-2.28
Current Ratio	0.25	1.28	2.60	2.69	0.72	3.08
Quick Ratio	0.12	0.68	1.27	1.39	0.43	1.96
Interest Coverage	-1.83	-1.96	-2.55	-0.77	1.11	0.02

Operating Efficiency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	23.48	23.73	23.54	25.04	19.36	24.12
Asset Turnover	0.42	0.76	0.75	0.59	0.65	0.78
Receivable days	103.80	83.03	93.30	91.61	90.71	85.18
Inventory Days	259.37	178.95	207.32	178.80	197.44	212.86
Payable days	124.32	48.80	49.29	44.91	46.14	90.47
Cash Conversion Cycle	238.85	213.18	251.32	225.50	242.02	207.56